ACUTE LEUKEMIA IN REMISSION
Clinical trials for ACUTE LEUKEMIA IN REMISSION explained in plain language.
Never miss a new study
Get alerted when new ACUTE LEUKEMIA IN REMISSION trials appear
Sign up with your email to follow new studies for ACUTE LEUKEMIA IN REMISSION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Could a cancer drug shield young transplant patients from a deadly complication?
Disease control OngoingThis study tests whether adding the drug vorinostat to standard care can prevent graft-versus-host disease (GVHD) in children, adolescents, and young adults receiving a bone marrow or blood stem cell transplant for blood cancers. Researchers are first finding the best dose of vor…
Matched conditions: ACUTE LEUKEMIA IN REMISSION
Phase: PHASE1, PHASE2 • Sponsor: University of Michigan Rogel Cancer Center • Aim: Disease control
Last updated Jun 23, 2026 19:17 UTC
-
Could a Weight-Loss drug protect your brain? new study investigates
Knowledge-focused TerminatedThis study looks at whether liraglutide (Saxenda®), a weight-loss medication, can increase a protein called BDNF that helps protect the brain. It involves 30 adults with multiple sclerosis, long-COVID, or leukemia in remission who also have obesity and memory or thinking issues. …
Matched conditions: ACUTE LEUKEMIA IN REMISSION
Phase: EARLY_PHASE1 • Sponsor: University of Chicago • Aim: Knowledge-focused
Last updated Jun 09, 2026 12:06 UTC